Geode Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-774,288
| Closed | -$106M | – | 4334 |
|
|
2020
Q3 | $106M | Sell |
774,288
-9,027
| -1% | -$960K | 0.02% | 588 |
|
|
2020
Q2 | $75.7M | Buy |
783,315
+97,397
| +14% | +$8.12M | 0.02% | 672 |
|
|
2020
Q1 | $32.2M | Buy |
685,918
+56,831
| +9% | +$3.64M | 0.01% | 1003 |
|
|
2019
Q4 | $45.9M | Buy |
629,087
+24,764
| +4% | +$1.5M | 0.01% | 1004 |
|
|
2019
Q3 | $31.5M | Buy |
604,323
+69,128
| +13% | +$3.68M | 0.01% | 1167 |
|
|
2019
Q2 | $26.8M | Buy |
535,195
+108,731
| +25% | +$5.29M | 0.01% | 1279 |
|
|
2019
Q1 | $22.2M | Buy |
426,464
+28,262
| +7% | +$1.3M | 0.01% | 1349 |
|
|
2018
Q4 | $19.5M | Buy |
398,202
+37,810
| +10% | +$2.08M | 0.01% | 1298 |
|
|
2018
Q3 | $23.5M | Buy |
360,392
+26,078
| +8% | +$1.53M | 0.01% | 1293 |
|
|
2018
Q2 | $16.6M | Buy |
334,314
+138,203
| +70% | +$6.69M | 0.01% | 1494 |
|
|
2018
Q1 | $9.57M | Buy |
196,111
+5,881
| +3% | +$306K | ﹤0.01% | 1798 |
|
|
2017
Q4 | $8.01M | Buy |
190,230
+4,565
| +2% | +$176K | ﹤0.01% | 1899 |
|
|
2017
Q3 | $7.96M | Buy |
185,665
+38,958
| +27% | +$1.24M | ﹤0.01% | 1893 |
|
|
2017
Q2 | $1.92M | Buy |
146,707
+11,977
| +9% | +$158K | ﹤0.01% | 2754 |
|
|
2017
Q1 | $1.77M | Buy |
134,730
+13,057
| +11% | +$167K | ﹤0.01% | 2739 |
|
|
2016
Q4 | $1.57M | Buy |
121,673
+23,871
| +24% | +$368K | ﹤0.01% | 2765 |
|
|
2016
Q3 | $1.6M | Buy |
97,802
+32,306
| +49% | +$583K | ﹤0.01% | 2687 |
|
|
2016
Q2 | $812K | Buy |
65,496
+1,795
| +3% | +$22.4K | ﹤0.01% | 3005 |
|
|
2016
Q1 | $682K | Buy |
63,701
+10,527
| +20% | +$95.8K | ﹤0.01% | 3077 |
|
|
2015
Q4 | $779K | Buy |
+53,174
| New | +$650K | ﹤0.01% | 3046 |
|
Geode Capital Management's MYOK Position: Q4 2020 in Review
Geode Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 774,288 shares — an estimated $106M sold.
Geode Capital Management first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $106M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Geode Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Geode Capital Management sold 774,288 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $106M.
- Geode Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Geode Capital Management's MyoKardia, Inc. Common Stock position peaked at $106M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.